Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2006 1
2007 1
2008 1
2009 1
2010 2
2011 2
2012 1
2013 2
2014 2
2015 3
2016 2
2017 2
2018 1
2019 4
2020 7
2021 10
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities.
Xu DH, Cullen BD, Tang M, Fang Y. Xu DH, et al. Curr Pharm Biotechnol. 2020;21(5):390-402. doi: 10.2174/1389201020666191202111534. Curr Pharm Biotechnol. 2020. PMID: 31793418 Clinical Trial.
BACKGROUND: Peripheral neuropathy can significantly impact the quality of life for those who are affected, as therapies from the current treatment algorithm often fail to deliver adequate symptom relief. ...CONCLUSION: Our findings demonstrate that the transdermal applicat …
BACKGROUND: Peripheral neuropathy can significantly impact the quality of life for those who are affected, as therapies from the curr …
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
Philpott HT, O'Brien M, McDougall JJ. Philpott HT, et al. Pain. 2017 Dec;158(12):2442-2451. doi: 10.1097/j.pain.0000000000001052. Pain. 2017. PMID: 28885454 Free PMC article.
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain. The aim of th …
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuro
Diversity of molecular targets and signaling pathways for CBD.
de Almeida DL, Devi LA. de Almeida DL, et al. Pharmacol Res Perspect. 2020 Dec;8(6):e00682. doi: 10.1002/prp2.682. Pharmacol Res Perspect. 2020. PMID: 33169541 Free PMC article. Review.
Cannabidiol (CBD) is the second most abundant component of the Cannabis plant and is known to have effects distinct from delta(9) -tetrahydrocannabinol (THC). ...Evidence derived from randomized clinical trials, in vitro and in vivo models and real-world observations suppo
Cannabidiol (CBD) is the second most abundant component of the Cannabis plant and is known to have effects distinct from delta(9) -te
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.
Harris HM, Sufka KJ, Gul W, ElSohly MA. Harris HM, et al. Planta Med. 2016 Aug;82(13):1169-72. doi: 10.1055/s-0042-106303. Epub 2016 May 23. Planta Med. 2016. PMID: 27214593
This research examined whether tetrahydocannabinol or cannabidiol alone could attenuate or prevent cisplatin-induced tactile allodynia. ...Cisplatin produced a reduction in g of force indicative of neuropathy that was attenuated by gabapentin, tetrahydocannabinol, a …
This research examined whether tetrahydocannabinol or cannabidiol alone could attenuate or prevent cisplatin-induced tactile allodyni …
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
Inglet S, Winter B, Yost SE, Entringer S, Lian A, Biksacky M, Pitt RD, Mortensen W. Inglet S, et al. Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2. Ann Pharmacother. 2020. PMID: 32483988 Review.
RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE: Based on identified data, the most robust evidence suggests that medical cannabis may be effective in the treatment of chemotherapy-induced nausea and vomiting, seizure disorders, MS-related spasticity, and pain (excluding diabetic …
RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE: Based on identified data, the most robust evidence suggests that medical cannabis may be ef …
Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series.
D'Andre S, McAllister S, Nagi J, Giridhar KV, Ruiz-Macias E, Loprinzi C. D'Andre S, et al. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211061739. doi: 10.1177/15347354211061739. Integr Cancer Ther. 2021. PMID: 34841942 Free PMC article.
BACKGROUND: Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, with limited treatment options. There is no literature on the use of topical cannabinoids for chemotherapy-induced neuropathy. CASE PRE …
BACKGROUND: Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, wi …
Medicinal cannabis.
Murnion B. Murnion B. Aust Prescr. 2015 Dec;38(6):212-5. doi: 10.18773/austprescr.2015.072. Epub 2015 Dec 1. Aust Prescr. 2015. PMID: 26843715 Free PMC article. Review.
Possible clinical indications include spasticity and pain in multiple sclerosis, cancer-associated nausea and vomiting, cancer pain and HIV neuropathy. However, evidence is limited, may reflect subjective rather than objective outcomes, and is not conclusive. ...Nabiximols …
Possible clinical indications include spasticity and pain in multiple sclerosis, cancer-associated nausea and vomiting, cancer pain and HIV …
Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA, Harley J, Casey SL, Vaughan AC, Winters BL, Vaughan CW. Mitchell VA, et al. Neuropharmacology. 2021 May 15;189:108529. doi: 10.1016/j.neuropharm.2021.108529. Epub 2021 Mar 16. Neuropharmacology. 2021. PMID: 33741405
The psychoactive and non-psychoactive constituents of cannabis, delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have synergistic analgesic efficacy in animal models of neuropathic pain when injected systemically. ...
The psychoactive and non-psychoactive constituents of cannabis, delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have synergi …
Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors.
Pereira AF, Lisboa MRP, de Freitas Alves BW, da Silva CMP, Dias DBS, de Menezes KLS, Cesário FRAS, de França JC, de Oliveira AR, Hallak JEC, Zuardi AW, Crippa JA, de Alencar NMN, Lima-Júnior RCP, Vale ML. Pereira AF, et al. Neurotox Res. 2021 Dec;39(6):1782-1799. doi: 10.1007/s12640-021-00442-x. Epub 2021 Nov 18. Neurotox Res. 2021. PMID: 34792764
Oxaliplatin-induced neurotoxicity is expressed as a dose-limiting peripheral sensory neuropathy (PSN). Cannabinoid substances have been investigated for the analgesic effect. ...The activation of the endocannabinoid system could be considered as a therapeutic target for co …
Oxaliplatin-induced neurotoxicity is expressed as a dose-limiting peripheral sensory neuropathy (PSN). Cannabinoid substances have be …
Effects of Cannabidiol and a Novel Cannabidiol Analog against Tactile Allodynia in a Murine Model of Cisplatin-Induced Neuropathy: Enhanced Effects of Sub-Analgesic Doses of Morphine.
Harris HM, Gul W, ElSohly MA, Sufka KJ. Harris HM, et al. Med Cannabis Cannabinoids. 2018 Jun 12;1(1):54-59. doi: 10.1159/000489077. eCollection 2018 Jun. Med Cannabis Cannabinoids. 2018. PMID: 34676322 Free PMC article.
OBJECTIVE: This research examined whether a cannabidiol (CBD)-opioid pharmacotherapy could attenuate cisplatin-induced tactile allodynia. ...
OBJECTIVE: This research examined whether a cannabidiol (CBD)-opioid pharmacotherapy could attenuate cisplatin-induced tactile allody …
38 results